ArticleInternal medicine (Tokyo, Japan)2026
Primary Gastric Alveolar Rhabdomyosarcoma.
Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary gastric alveolar rhabdomyosarcoma (RMS) is an extremely rare condition. We report a case of a 32-year-old man who presented with abdominal distension and anorexia. Imaging revealed a gastric mass with peritoneal dissemination and vertebral metastasis. Endoscopy revealed a large, ulcerative lesion. Histopathology revealed small round cells in an alveolar pattern that were positive for desmin and myogenin. Despite the initiation of multimodal therapy, the patient developed septic shock and died 10 days after treatment. This case highlights the aggressive nature of primary gastric alveolar RMS and emphasizes the importance of integrated diagnostic approaches, including histopathological, immunohistochemical, and molecular analyses, for its accurate diagnosis and appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.